Premium
Inhibition of Puerperal Lactation: Pyridoxine of no Benefit
Author(s) -
Fleming J. Stewart
Publication year - 1977
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1111/j.1479-828x.1977.tb02605.x
Subject(s) - lactation , pyridoxine , placebo , medicine , endocrinology , pregnancy , biology , alternative medicine , genetics , pathology
Summary: A double‐blind trial comparing the efficacy of pyridoxine, stilboestrol and a placebo showed stilboestrol to be clearly superior in the inhibition of puerperal lactation, pyridoxine being only marginally more effective than a placebo. By advising patients to restrict their fluid intake and support the breasts, it was possible to employ a relatively low total dose of stilboestrol of 75 mg over 5 days.